Lung function trajectories in children with cystic fibrosis aged 3-17 years: impact of elexacaftor-tezacaftor-ivacaftor on lung function
- DOI
- 10.64898/2026.08.31.26361791
- Published
- 2026-09-02
- Container
- Not recorded
- Publisher
- openRxiv
- Open access
- unknown
Credibility signals
uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.64898/2026.08.31.26361791,
title = {Lung function trajectories in children with cystic fibrosis aged 3-17 years: impact of elexacaftor-tezacaftor-ivacaftor on lung function},
author = {Brett P Dyer and Maddy Deery and Rebecca Heyman and Paul D Robinson and Claire E Wainwright and Peter D Sly and Robert S Ware and Tamara L Blake},
year = {2026},
doi = {10.64898/2026.08.31.26361791},
url = {https://doi.org/10.64898/2026.08.31.26361791}
}RIS
TY - JOUR TI - Lung function trajectories in children with cystic fibrosis aged 3-17 years: impact of elexacaftor-tezacaftor-ivacaftor on lung function AU - Brett P Dyer AU - Maddy Deery AU - Rebecca Heyman AU - Paul D Robinson AU - Claire E Wainwright AU - Peter D Sly AU - Robert S Ware AU - Tamara L Blake PY - 2026 DO - 10.64898/2026.08.31.26361791 UR - https://doi.org/10.64898/2026.08.31.26361791 ER -
APA
Dyer, B. P., Deery, M., Heyman, R., Robinson, P. D., Wainwright, C. E., Sly, P. D., Ware, R. S., & Blake, T. L. (2026). Lung function trajectories in children with cystic fibrosis aged 3-17 years: impact of elexacaftor-tezacaftor-ivacaftor on lung function. https://doi.org/10.64898/2026.08.31.26361791
Source records
- crossref · retrieved 2026-09-25T18:17:02.625Z